To further grow its already indecent streams of income, New York-based pharmaceutical big shot, Bristol-Myers Squibb is partnering with Tsinghua University in communist China to develop new drugs for cancers and autoimmune related diseases. According to the U.S. Department of State This poses a problem because Tsinghua University is a threat to national security as it has once launched cyber attacks against America and it has a clear connection to the Chinese Communist Party (CCP).
The present CCP leader Xi Jinping claims Tsinghua University as his alma mater, which partly explains the school’s “Marxist” journalism, that is training the next generation of Chinese-run state media propagandists on how to deceive Chinese people and the world at large. It turns out that back in 2013, Bristol-Myers Squibb went into partnership with Tsinghua University for autoimmune target discovery and structural biology, and this is just an extension of that collective research effort.
The news is yet to ease off on the fact that there is still a bit of controversy over the ties between Big Pharma and communist China that many now believe is responsible for the unleashing of the Wuhan corona virus.